Search Results 231-240 of 17314 for Cyclophosphamide

  1. A Study of the Biological Characteristics of Lupus - Mayo Clinic

    Age <18 · Has chronic infectious disease · Has cancer and is on chemotherapy · CNS lupus · Drug-induced lupus · Is on IV steroids or cyclophosphamide · Pregnant.

  2. Safety and Efficacy of ALLO-605 an Anti-BCMA Allogeneic CAR T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma - Mayo Clinic

    ... cyclophosphamide, and ALLO-647. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments ...

  3. Publications - Antonious Z. Hazim, M.D. - Mayo Clinic

    ... cyclophosphamide. Eur Heart J Open. 2024 Jan; 4 (1):oead130 Epub 2023 Dec 08. View PubMed; Banks SA, Bhatti MT, Go RS, Abeykoon JP, Acosta-Medina AA, Hazim AZ ...

  4. Controlled Low Calorie Diet in Reducing Side Effects and Increasing Response to Chemotherapy in Patients With Breast or Prostate Cancer - Mayo Clinic

    Prostate cancer subjects may have received prior treatment with metronomic cyclophosphamide as this is considered anti-angiogenic/immunomodulatory and not ...

  5. A Study of Pembrolizumab (MK-3475) Versus Placebo in Combination with Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer - Mayo Clinic

    ... cyclophosphamide) or 6 months (for participants who did not receive cyclophosphamide) after the last dose of study treatment and refrain from donating sperm ...

  6. Bone Marrow Transplant Clinical Trials - Mayo Clinic Research

    ... cyclophosphamide, bortezomib and dexamethasone versus chemotherapy with Dara ... The purpose of this study is to look at the effectiveness of using a study drug ...

  7. Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma - Mayo Clinic

    Drugs used in chemotherapy, such as vincristine sulfate, doxorubicin hydrochloride, cyclophosphamide, ifosfamide, and etoposide, work in different ways to ...

  8. AKT Inhibitor MK2206, Combined with Bendamustine Hydrochloride, and Rituximab for Treating Patients who have Relapsed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

    ... cyclophosphamide and rituximab (FCR) or pentostatin, cyclophosphamide and rituximab (PCR); PHASE II ONLY: FISH abnormality of 17P deletions; (note: patients ...

  9. Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic Chemotherapy - Mayo Clinic

    ... cyclophosphamide [AC]). Cisplatin at a dose of ≥70mg/m^2, with or without other chemotherapy agent(s) OR; Anthracycline (60 mg/m^2) plus cyclophosphamide(600 ...

  10. Diagnosed with focal segmental glomerulosclerosis (FSGS)? Here's what to know about your treatment options - Mayo Clinic

    ... cyclophosphamide (Cytoxan) or adrenocorticotropic hormone (ACTH), among others. As always, talk with your care team about your options, including ...